Header Logo

Connection

ANN SCHEIMANN to Early Termination of Clinical Trials

Back to Details
This is a "connection" page, showing publications ANN SCHEIMANN has written about Early Termination of Clinical Trials.
ANN SCHEIMANN
Connection Strength
0.036
Early Termination of Clinical Trials
  1. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2017 12; 19(12):1751-1761.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.